Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
Flaherty, Keith T, Gray, Robert J, Chen, Alice P, Li, Shuli, McShane, Lisa M, Patton, David, Hamilton, Stanley R, Williams, P Mickey, Iafrate, A John, Sklar, Jeffrey, Mitchell, Edith P, Harris, Lyndsay N, Takebe, Naoko, Sims, David J, Coffey, Brent, Fu, Tony, Routbort, Mark, Zwiebel, James A, Rubinstein, Larry V, Little, Richard F, Arteaga, Carlos L, Comis, Robert, Abrams, Jeffrey S, O'Dwyer, Peter J, Conley, Barbara A
Published in Journal of clinical oncology (20.11.2020)
Published in Journal of clinical oncology (20.11.2020)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies
RAMALINGAM, Suresh S, PARISE, Robert A, BELANI, Chandra P, RAMANANTHAN, Ramesh K, LAGATTUTA, Theodore F, MUSGUIRE, Lori A, STOLLER, Ronald G, POTTER, Douglas M, ARGIRIS, Athanassios E, ZWIEBEL, James A, EGORIN, Merrill J
Published in Clinical cancer research (15.06.2007)
Published in Clinical cancer research (15.06.2007)
Get full text
Journal Article
A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
JIANQING LIN, GILBERT, Jill, DONEHOWER, Ross C, CARDUCCI, Michael A, RUDEK, Michelle A, ZWIEBEL, James A, GORE, Steve, JIEMJIT, Anchalee, MING ZHAO, BAKER, Sharyn D, AMBINDER, Richard F, HERMAN, James G
Published in Clinical cancer research (01.10.2009)
Published in Clinical cancer research (01.10.2009)
Get full text
Journal Article
Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion
MCNEEL, Douglas G, EICKHOFF, Jens, JIANLIANG ZHANG, HAMMERSHAIMB, Luz, ZWIEBEL, James A, WILDING, George, LEE, Fred T, KING, David M, ALBERTI, Dona, THOMAS, James P, FRIEDL, Andreas, KOLESAR, Jill, MARNOCHA, Rebecca, VOLKMAN, Jennifer
Published in Clinical cancer research (01.11.2005)
Published in Clinical cancer research (01.11.2005)
Get full text
Journal Article
Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results
LANG, Frederick F, BRUNER, Janet M, CHANDLER, William, ZWIEBEL, James A, KAPLAN, Richard S, YUNG, W. K, FULLER, Gregory N, ALDAPE, Kenneth, PRADOS, Michael D, CHANG, Susan, BERGER, Mitchel S, MCDERMOTT, Michael W, KUNWAR, Sandeep M, JUNCK, Larry R
Published in Journal of clinical oncology (01.07.2003)
Published in Journal of clinical oncology (01.07.2003)
Get full text
Journal Article
A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer
FAKIH, Marwan G, PENDYALA, Lakshmi, EGORIN, Merrill J, FETTERLY, Gerald, TOTH, Karoli, ZWIEBEL, James A, ESPINOZA-DELGADO, Igor, LITWIN, Alan, RUSTUM, Youcef M, ROSS, Mary Ellen, HOLLERAN, Julianne L
Published in Clinical cancer research (01.05.2009)
Published in Clinical cancer research (01.05.2009)
Get full text
Journal Article
Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity
MARCUCCI, Guide, STOCK, Wendy, MORAN, Mollie, MAHARRY, Kati, NOVICK, Steven, BLOOMFIELD, Clara D, ZWIEBEL, James A, LARSON, Richard A, GREVER, Michael R, CHAN, Kenneth K, BYRD, John C, GUOWEI DAI, KLISOVIC, Rebecca B, SHUJUN LIU, KLISOVIC, Marko I, BLUM, William, KEFAUVER, Cheryl, SHER, Dorie A, GREEN, Margaret
Published in Journal of clinical oncology (20.05.2005)
Published in Journal of clinical oncology (20.05.2005)
Get full text
Journal Article
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
Chae, Young K, Hong, Fangxin, Vaklavas, Christos, Cheng, Heather H, Hammerman, Peter, Mitchell, Edith P, Zwiebel, James A, Ivy, S Percy, Gray, Robert J, Li, Shuli, McShane, Lisa M, Rubinstein, Larry V, Patton, David, Williams, P Mickey, Hamilton, Stanley R, Mansfield, Aaron, Conley, Barbara A, Arteaga, Carlos L, Harris, Lyndsay N, O'Dwyer, Peter J, Chen, Alice P, Flaherty, Keith T
Published in Journal of clinical oncology (20.07.2020)
Published in Journal of clinical oncology (20.07.2020)
Get full text
Journal Article
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer
Sridhar, Srikala S., Canil, Christina M., Chi, Kim N., Hotte, Sebastien J., Ernst, Scott, Wang, Lisa, Chen, Eric X., Juhasz, Agnes, Yen, Yun, Murray, Peter, Zwiebel, James A., Moore, Malcolm J.
Published in Cancer chemotherapy and pharmacology (01.04.2011)
Published in Cancer chemotherapy and pharmacology (01.04.2011)
Get full text
Journal Article
Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase, in Combination with High-Dose Cytarabine in Patients with Acute Myeloid Leukemia
KLISOVIC, Rebecca B, BLUM, William, ZWIEBEL, James A, DEVINE, Steven, BYRD, John C, GREVER, Michael R, CHAN, Kenneth, MARCUCCI, Guido, XIAOHUI WEI, SHUJUN LIU, ZHONGFA LIU, ZHILIANG XIE, VUKOSAVLJEVIC, Tamara, KEFAUVER, Cheryl, HUYNH, Lenguyen, JIUXIA PANG
Published in Clinical cancer research (15.06.2008)
Published in Clinical cancer research (15.06.2008)
Get full text
Journal Article
Phase I Trial of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Doxorubicin and Cyclophosphamide in Children With Relapsed Solid Tumors: A Children's Oncology Group Study
Rheingold, Susan R, Hogarty, Michael D, Blaney, Susan M, Zwiebel, James A, Sauk-Schubert, Calies, Chandula, Reddy, Krailo, Mark D, Adamson, Peter C
Published in Journal of clinical oncology (20.04.2007)
Published in Journal of clinical oncology (20.04.2007)
Get full text
Journal Article
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study
Azad, Nilofer S, Gray, Robert J, Overman, Michael J, Schoenfeld, Jonathan D, Mitchell, Edith P, Zwiebel, James A, Sharon, Elad, Streicher, Howard, Li, Shuli, McShane, Lisa M, Rubinstein, Larry, Patton, David R, Williams, P Mickey, Coffey, Brent, Hamilton, Stanley R, Bahary, Nathan, Suga, J Marie, Hatoum, Hassan, Abrams, Jeffrey S, Conley, Barbara A, Arteaga, Carlos L, Harris, Lyndsay, O'Dwyer, Peter J, Chen, Alice P, Flaherty, Keith T
Published in Journal of clinical oncology (20.01.2020)
Published in Journal of clinical oncology (20.01.2020)
Get full text
Journal Article
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial
Kalinsky, Kevin, Hong, Fangxin, McCourt, Carolyn K, Sachdev, Jasgit C, Mitchell, Edith P, Zwiebel, James A, Doyle, L Austin, McShane, Lisa M, Li, Shuli, Gray, Robert J, Rubinstein, Larry V, Patton, David, Williams, Paul M, Hamilton, Stanley R, Conley, Barbara A, O'Dwyer, Peter J, Harris, Lyndsay N, Arteaga, Carlos L, Chen, Alice P, Flaherty, Keith T
Published in JAMA oncology (01.02.2021)
Published in JAMA oncology (01.02.2021)
Get more information
Journal Article
Differential Outcomes in Codon 12/13 and Codon 61 NRAS -Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS -Mutated Tumors
Cleary, James M, Wang, Victoria, Heist, Rebecca S, Kopetz, E Scott, Mitchell, Edith P, Zwiebel, James A, Kapner, Kevin S, Chen, Helen X, Li, Shuli, Gray, Robert J, McShane, Lisa M, Rubinstein, Larry V, Patton, David R, Meric-Bernstam, Funda, Dillmon, Melissa S, Williams, P Mickey, Hamilton, Stanley R, Conley, Barbara A, Aguirre, Andrew J, O'Dwyer, Peter J, Harris, Lyndsay N, Arteaga, Carlos L, Chen, Alice P, Flaherty, Keith T
Published in Clinical cancer research (01.06.2021)
Published in Clinical cancer research (01.06.2021)
Get full text
Journal Article
Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual
Massett, Holly A, Mishkin, Grace, Rubinstein, Larry, Ivy, S Percy, Denicoff, Andrea, Godwin, Elizabeth, DiPiazza, Kate, Bolognese, Jennifer, Zwiebel, James A, Abrams, Jeffrey S
Published in Clinical cancer research (15.11.2016)
Published in Clinical cancer research (15.11.2016)
Get full text
Journal Article
A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer: A Study of the PMH Phase II Consortium
Leighl, Natasha B., Laurie, Scott A., Chen, Xueyu E., Ellis, Peter, Shepherd, Frances A., Knox, Jennifer J., Goss, Glenwood, Burkes, Ronald L., Pond, Gregory R., Dick, Christopher, Yen, Yun, Zwiebel, James A., Moore, Malcolm J.
Published in Journal of thoracic oncology (01.09.2009)
Published in Journal of thoracic oncology (01.09.2009)
Get full text
Journal Article
Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma
Woyach, Jennifer A, Kloos, Richard T, Ringel, Matthew D, Arbogast, Daria, Collamore, Minden, Zwiebel, James A, Grever, Michael, Villalona-Calero, Miguel, Shah, Manisha H
Published in The journal of clinical endocrinology and metabolism (01.01.2009)
Published in The journal of clinical endocrinology and metabolism (01.01.2009)
Get full text
Journal Article
Dabrafenib and Trametinib in Patients With Tumors With BRAF V600E Mutations: Results of the NCI-MATCH Trial Subprotocol H
Salama, April K S, Li, Shuli, Macrae, Erin R, Park, Jong-In, Mitchell, Edith P, Zwiebel, James A, Chen, Helen X, Gray, Robert J, McShane, Lisa M, Rubinstein, Larry V, Patton, David, Williams, P Mickey, Hamilton, Stanley R, Armstrong, Deborah K, Conley, Barbara A, Arteaga, Carlos L, Harris, Lyndsay N, O'Dwyer, Peter J, Chen, Alice P, Flaherty, Keith T
Published in Journal of clinical oncology (20.11.2020)
Published in Journal of clinical oncology (20.11.2020)
Get full text
Journal Article
Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Results of the NCI-MATCH Trial Subprotocol H
Salama, April K S, Li, Shuli, Macrae, Erin R, Park, Jong-In, Mitchell, Edith P, Zwiebel, James A, Chen, Helen X, Gray, Robert J, McShane, Lisa M, Rubinstein, Larry V, Patton, David, Williams, P Mickey, Hamilton, Stanley R, Armstrong, Deborah K, Conley, Barbara A, Arteaga, Carlos L, Harris, Lyndsay N, O'Dwyer, Peter J, Chen, Alice P, Flaherty, Keith T
Published in Journal of clinical oncology (20.11.2020)
Published in Journal of clinical oncology (20.11.2020)
Get full text
Journal Article
Phase II Study of Taselisib in PIK3CA -Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I
Krop, Ian E, Jegede, Opeyemi A, Grilley-Olson, Juneko E, Lauring, Josh D, Mitchell, Edith P, Zwiebel, James A, Gray, Robert J, Wang, Victoria, McShane, Lisa M, Rubinstein, Larry V, Patton, David, Williams, P Mickey, Hamilton, Stanley R, Kono, Scott A, Ford, James M, Garcia, Agustin A, Sui, Xingwei D, Siegel, Robert D, Slomovitz, Brian M, Conley, Barbara A, Arteaga, Carlos L, Harris, Lyndsay N, O'Dwyer, Peter J, Chen, Alice P, Flaherty, Keith T
Published in JCO precision oncology (01.02.2022)
Published in JCO precision oncology (01.02.2022)
Get more information
Journal Article